Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.881
Filter
1.
Int Ophthalmol ; 44(1): 308, 2024 Jul 03.
Article in English | MEDLINE | ID: mdl-38958789

ABSTRACT

PURPOSE: This study aimed to investigate the demographics, clinical characteristics, and management outcomes of patients with acute infectious endophthalmitis (AIE). METHODS: This retrospective chart review was conducted on all patients admitted with the clinical diagnosis of infectious endophthalmitis from 2017 to 2022. Demographic data, patients' clinical characteristics, the type of acute infectious endophthalmitis (post-operative, post-traumatic, bleb-associated, and endogenous endophthalmitis), the type of surgical procedure in the post-operative cases, the microbiologic analysis results of vitreous samples, therapeutic measures, and visual outcomes of patients were recorded. RESULTS: In this study, 182 participants, including 122 male (67%) and 60 (33%) female, were involved. The mean age of patients was 54.56 ± 21 years, with a range of 1-88 years old. The most prevalent type of AIE was post-operative (59.9%), followed by endogenous (19.2%), post-traumatic (17%), and bleb-associated (3.8%). The most common type of intraocular surgery in the post-operative subgroups of AIE patients was phacoemulsification (57.8%). The median (interquartile range) of the primary and final BCVA of patients was 1.5 (1.35, 1.85) and 0.65 (0.35, 1.35), respectively. Vitreous haziness grade (OR, 2.89; 95% CI, 1.11-5.74; p = 0.009) and the primary VA (OR, 60.34; 95% CI, 2.87-126.8; p = 0.008) revealed statistical significance for final vision loss. CONCLUSION: AIE is a devastating condition with poor visual outcomes, which presents with acute inflammatory signs and symptoms regardless of its type. However, prompt and appropriate treatment leads to visual recovery to a functional level in many patients.


Subject(s)
Endophthalmitis , Eye Infections, Bacterial , Visual Acuity , Humans , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Endophthalmitis/epidemiology , Endophthalmitis/therapy , Male , Female , Retrospective Studies , Middle Aged , Aged , Adult , Aged, 80 and over , Adolescent , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/epidemiology , Eye Infections, Bacterial/therapy , Young Adult , Acute Disease , Child , Child, Preschool , Infant , Anti-Bacterial Agents/therapeutic use , Vitreous Body/microbiology , Vitreous Body/pathology , Vitrectomy/methods
2.
Turk J Ophthalmol ; 54(3): 175-179, 2024 06 28.
Article in English | MEDLINE | ID: mdl-38860516

ABSTRACT

A 78-year-old man with a history of lung cancer, chemotherapy, radiotherapy, and coronavirus disease 2019 infection experienced visual deterioration of two-weeks' duration in his right eye. There was multifocal, yellowish-white retinitis foci, vascular engorgement, and scattered intraretinal hemorrhages extending from posterior pole to retinal periphery in the right eye, whereas the left eye was normal. Intravitreal vancomycin, ceftazidime, clindamycin, and dexamethasone were given for endogenous endophthalmitis initially. Vitreous culture confirmed the presence of Aspergillus lentulus, and he was treated with intravitreal amphotericin-B and voriconazole injections together with systemic amphotericin-B, voriconazole, posaconazole, and micafungin therapy. During follow-up, vitreoretinal surgery was performed because of rhegmatogenous retinal detachment, and he received one additional cycle of chemotherapy due to recurrence of the cancer. Although the retina was attached, enucleation was eventually required due to painful red eye. Atypical squamous cells beneath the neurosensory retina suggesting metastasis were noted on histopathological examination. Timely ocular examination is crucial for any immunocompromised patient having ocular symptoms. High level of suspicion for a fungal etiology is a must in these patients.


Subject(s)
Aspergillosis , Aspergillus , Endophthalmitis , Eye Infections, Fungal , Immunocompromised Host , Lung Neoplasms , Humans , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Male , Aged , Eye Infections, Fungal/diagnosis , Eye Infections, Fungal/microbiology , Lung Neoplasms/diagnosis , Aspergillosis/diagnosis , Aspergillosis/microbiology , Aspergillus/isolation & purification , Antifungal Agents/therapeutic use , COVID-19/complications , Vitreous Body/microbiology , Intravitreal Injections , SARS-CoV-2
3.
J Infect Public Health ; 17(7): 102461, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38852231

ABSTRACT

Endogenous bacterial endophthalmitis (EE) is an intraocular infection with a poor prognosis. Timely diagnosis and prompt treatment are crucial to prevent vision loss. In this communication, we describe a case of EE caused by Streptococcus pyogenes (Group A Streptococcus [GAS]) in an HIV-positive patient with poorly controlled type 2 diabetes mellitus (DM). A 60-year-old man with a history of HIV and poorly controlled type 2 diabetes, presented with progressive blurry vision, left eye pain, redness, and headache. EE was diagnosed based on the clinical presentation and gram stain analysis of blood culture. Treatment with vitreous tap, intravitreal, topical antibiotics, and systemic antibiotics significantly improved the patient's symptoms. The case highlights the rarity of GAS as a causative agent of EE, particularly in patients with risk factors such as HIV infection and DM.


Subject(s)
Anti-Bacterial Agents , Diabetes Mellitus, Type 2 , Endophthalmitis , HIV Infections , Streptococcal Infections , Streptococcus pyogenes , Humans , Endophthalmitis/microbiology , Endophthalmitis/drug therapy , Endophthalmitis/diagnosis , Male , Middle Aged , HIV Infections/complications , HIV Infections/drug therapy , Diabetes Mellitus, Type 2/complications , Anti-Bacterial Agents/therapeutic use , Streptococcal Infections/complications , Streptococcal Infections/drug therapy , Streptococcal Infections/microbiology , Streptococcal Infections/diagnosis , Streptococcus pyogenes/isolation & purification , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/complications
4.
Medicina (Kaunas) ; 60(6)2024 May 29.
Article in English | MEDLINE | ID: mdl-38929513

ABSTRACT

We present a case of bilateral endogenous endophthalmitis with an extremely rare etiology of Capnocytophaga canimorsus. A 42-year-old asplenic patient with bilateral deterioration of visual acuity presented to the Emergency Department. The sudden deterioration of visual acuity, which prompted the patient to visit the ophthalmologist, was the first sign of the onset of sepsis. The physicians' attention, in addition to poor visual acuity and intense inflammation on ophthalmologic examination, was drawn to the reported flu-like symptoms. They were accompanied by high C-reactive protein results and abnormalities in echocardiography. A blood culture isolated the bacterium Capnocytophaga canimorsus. Immunocompromised patients are particularly susceptible to C. canimorsus infection. Endophthalmitis of this etiology has a very aggressive course, both ophthalmic and systemic. Therefore, quick diagnosis and initiation of adequate therapy are crucial.


Subject(s)
Capnocytophaga , Endophthalmitis , Gram-Negative Bacterial Infections , Sepsis , Humans , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Capnocytophaga/isolation & purification , Adult , Sepsis/complications , Sepsis/microbiology , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/complications , Male , Anti-Bacterial Agents/therapeutic use
5.
BMC Ophthalmol ; 24(1): 214, 2024 May 17.
Article in English | MEDLINE | ID: mdl-38760776

ABSTRACT

BACKGROUND: Endogenous endophthalmitis (EE) is a rare but highly destructive eye emergency secondary to systemic infection. Acute endophthalmitis can lead to irreversible vision impairment or even loss of the whole eye, unless being diagnosed and treated promptly. CASE PRESENTATION: This study reports three typical EE cases of endogenous endophthalmitis secondary to different severe systemic diseases. Patients were recruited from the Department of ophthalmology at Zhongnan hospital of Wuhan University and the Department of ophthalmology at the Second Affiliated Hospital of Fujian Medical University. Patients were followed up for up to 60 days. Among these cases, the eye symptoms is the initial manifestations while secondary to original different special systemic conditions. Patients have been treated under dynamically prompt response undergoing systemic treatment and eye treatment at the same time. Best corrected visual acuity were 20/40, 20/60 and light perception during follow-up evaluation. CONCLUSIONS: Our observation suggest that prompt identification and treatment could save patients' vision from EE.


Subject(s)
Endophthalmitis , Eye Infections, Bacterial , Visual Acuity , Humans , Anti-Bacterial Agents/therapeutic use , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/drug therapy , Visual Acuity/physiology
6.
Int Ophthalmol ; 44(1): 216, 2024 May 05.
Article in English | MEDLINE | ID: mdl-38705908

ABSTRACT

PURPOSE: To evaluate clinical features, treatment protocol, outcomes, and complications that developed in this case series of 24 patients who had consecutive sterile endophthalmitis after intravitreal bevacizumab (IVB) injection. METHODS: In this retrospective case series, IVB was repackaged in individual aliquots from the three batches that were used on the same day. IVB was injected into 26 eyes of 26 patients due to diabetic macular edema, age-related macular degeneration, and branch retinal vein occlusion. All patients had intraocular inflammation. Patients were divided into two groups severe and moderate inflammation according to the intraocular inflammation. The medical records of all patients were reviewed. At each follow-up visit, the complete ophthalmologic examination was performed, including best corrected visual acuity (BCVA), intraocular pressure, biomicroscopy, and posterior fundus examination. RESULTS: Twenty-four of 26 patients were included in the study. Two patients were excluded from this study since they didn't come to follow-up visits. The mean BCVA was 1.00 ± 0.52 Log MAR units before IVB. At the final visit, the BCVA was 1.04 ± 0.47 Log MAR units. These differences were not significant (p = 0.58). Of the 24 eyes, 16 eyes had severe, and 8 eyes had moderate intraocular inflammation. Eleven eyes in the severe inflammation group underwent pars plana vitrectomy due to intense vitreous opacity. Smear, culture results, and polymerase chain reaction results were negative. CONCLUSION: Sterile endophthalmitis may occur after IVB injection. Differential diagnosis of sterile endophthalmitis from infective endophthalmitis is crucial to adjust the appropriate treatment and prevent long-term complications due to unnecessary treatment.


Subject(s)
Angiogenesis Inhibitors , Bevacizumab , Endophthalmitis , Intravitreal Injections , Visual Acuity , Humans , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Endophthalmitis/diagnosis , Endophthalmitis/etiology , Retrospective Studies , Male , Female , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Aged , Middle Aged , Aged, 80 and over , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Macular Edema/drug therapy , Macular Edema/diagnosis , Macular Edema/etiology , Retinal Vein Occlusion/diagnosis , Retinal Vein Occlusion/drug therapy , Retinal Vein Occlusion/complications , Follow-Up Studies , Diabetic Retinopathy/diagnosis , Diabetic Retinopathy/drug therapy
7.
Int Ophthalmol ; 44(1): 225, 2024 May 15.
Article in English | MEDLINE | ID: mdl-38748185

ABSTRACT

PURPOSE: To evaluate the importance of the status of posterior vitreous in eyes with endophthalmitis following intravitreal anti-vascular endothelial growth factor (anti-VEGF). METHODS: The absence or existence of posterior vitreous detachment (PVD) was elicited in 23 eyes of 23 patients with injection related endophthalmitis, during pars plana vitrectomy (PPV) and compared with 24 control eyes of 24 patients who received intravitreal anti-VEGF without any complication. RESULTS: Thirtten (54.2%) out of 24 patients in the control group had full PVD, whereas only 2 (9.5%) out of 23 eyes in endophthalmitis group (p < 0.001) had full PVD. In all eyes without PVD, posterior vitreous was inducted to be detached at least from optic nerve and macular area without any iatrogenic tear. CONCLUSION: The absence of PVD is a factor that increases the risk of endophthalmitis after intravitreal injections. Uncomplicated separation of the posterior vitreous from the retina in PPV contributes to better prognosis.


Subject(s)
Angiogenesis Inhibitors , Endophthalmitis , Intravitreal Injections , Vascular Endothelial Growth Factor A , Vitrectomy , Vitreous Detachment , Humans , Endophthalmitis/etiology , Endophthalmitis/diagnosis , Endophthalmitis/epidemiology , Intravitreal Injections/adverse effects , Male , Female , Angiogenesis Inhibitors/administration & dosage , Angiogenesis Inhibitors/adverse effects , Risk Factors , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Aged , Middle Aged , Vitrectomy/adverse effects , Vitrectomy/methods , Vitreous Body , Ranibizumab/administration & dosage , Ranibizumab/adverse effects , Bevacizumab/administration & dosage , Bevacizumab/adverse effects , Aged, 80 and over
8.
Ned Tijdschr Geneeskd ; 1682024 May 20.
Article in Dutch | MEDLINE | ID: mdl-38780203

ABSTRACT

The general physician as well as the medical specialist may be confronted with a patient with one or two red eyes. To be adequately equipped we answer a series of questions on diagnosis, treatment and referral of patients with red eyes after trauma, or with conjunctivitis, keratitis, scleritis, uveïtis, endophthalmitis or acute glaucoma. Refer to an ophthalmologist or not?


Subject(s)
Eye Diseases , Humans , Acute Disease , Conjunctivitis/diagnosis , Conjunctivitis/etiology , Diagnosis, Differential , Endophthalmitis/diagnosis , Eye Diseases/diagnosis , Referral and Consultation , Scleritis/diagnosis , Scleritis/drug therapy
9.
Medicina (Kaunas) ; 60(5)2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38792883

ABSTRACT

We present a case of endogenous endophthalmitis with urinary tract infection (UTI) caused by group B Streptococcus (GBS). An 86-year-old female initially presented with ocular pain and sudden visual disturbance of the left eye. The patient did not complain of other symptoms and had no history of recent ocular surgery or trauma. Endogenous endophthalmitis was clinically diagnosed based on ophthalmic examination, history, and lab results showing systemic infection. A few days later, GBS was identified in her aqueous humor, blood, and urine cultures. Intravitreal ceftazidime and vancomycin injections, as well as fortified ceftazidime and vancomycin eye drops, were used immediately after clinical diagnosis. However, the symptoms worsened despite repeated intravitreal injections, so evisceration was performed. Endogenous endophthalmitis caused by GBS is very virulent and may present without evident systemic symptoms. The early recognition of the disease and systemic work up, followed by prompt treatment, is necessary.


Subject(s)
Anti-Bacterial Agents , Endophthalmitis , Streptococcal Infections , Streptococcus agalactiae , Urinary Tract Infections , Humans , Female , Urinary Tract Infections/diagnosis , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , Urinary Tract Infections/complications , Aged, 80 and over , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Endophthalmitis/drug therapy , Streptococcus agalactiae/isolation & purification , Streptococcal Infections/drug therapy , Streptococcal Infections/diagnosis , Anti-Bacterial Agents/therapeutic use , Vancomycin/therapeutic use , Ceftazidime/therapeutic use , Ceftazidime/administration & dosage
10.
Transl Vis Sci Technol ; 13(5): 14, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38767905

ABSTRACT

Purpose: Extracellular vesicles (EVs) are messenger pigeons of the cells that communicate about cellular microenvironment. In this study, we evaluated the expression of C8α and calpain-2 in EVs from vitreous of patients with bacterial endophthalmitis to assess its utility as a diagnostic marker. Methods: EVs were isolated from vitreous of patients with bacterial endophthalmitis (culture positive and culture negative) and noninfectious control by exosome isolation reagent and characterized, and the levels of C8α and calpain-2 was assessed by enzyme-linked immunosorbent assay in isolated EVs and direct vitreous. The receiver operating characteristic curve was generated to assess the diagnostic performance. Results: Scanning electron microscopy (SEM) and dynamic light scattering (DLS) confirmed the presence of EVs having a diameter (nm) of 275.2 ± 93, 92 ± 22, and 77.28 ± 12 in culture-positive (CP), culture-negative (CN), and control respectively. The expression level (ng/mL) of C8α in the EVs obtained from CP was 144 ± 22 and CN was 31.2 ± 9.8, which was significantly higher (P < 0.01) than control 3.7 ± 2.4. Interestingly, C8α is not expressed directly in the vitreous of CN and controls. Calpain-2 was significantly downregulated (P ≤ 0.0001) in CP (0.94 ± 0.16) and CN (0.70 ± 0.14) than control. The sensitivity and specificity of 1 for C8α and calpain-2 in the EVs implied that its diagnostic accuracy was significant. Conclusions: This study showed that the EV proteins C8α and calpain-2 could be suitable diagnostic markers for endophthalmitis. However, the presence of C8α in the EVs of CN samples but not in direct vitreous promises EVs as the future of diagnostics. Translational Relevance: Expression levels of EV-calpain-2 and EV-C8α could diagnose CN bacterial endophthalmitis.


Subject(s)
Biomarkers , Calpain , Endophthalmitis , Extracellular Vesicles , Vitreous Body , Calpain/metabolism , Humans , Vitreous Body/metabolism , Vitreous Body/microbiology , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Endophthalmitis/metabolism , Endophthalmitis/pathology , Extracellular Vesicles/metabolism , Biomarkers/metabolism , Male , Female , Middle Aged , Enzyme-Linked Immunosorbent Assay , Aged , Eye Infections, Bacterial/microbiology , Eye Infections, Bacterial/diagnosis , Eye Infections, Bacterial/metabolism , Eye Infections, Bacterial/pathology , ROC Curve , Microscopy, Electron, Scanning , Adult
13.
JAMA Ophthalmol ; 142(5): 486-487, 2024 May 01.
Article in English | MEDLINE | ID: mdl-38573613

ABSTRACT

A 71-year-old woman had 2 months of worsening vision and pain in her right eye. Examination revealed retrocorneal plaque, peaking of the pupil, and temporal prominent scleral vessels with inferotemporal scleral thinning. What would you do next?


Subject(s)
Anterior Eye Segment , Postoperative Complications , Humans , Anterior Eye Segment/diagnostic imaging , Anterior Eye Segment/pathology , Female , Male , Aged , Middle Aged , Inflammation/etiology , Endophthalmitis/etiology , Endophthalmitis/diagnosis , Uveitis, Anterior/etiology , Uveitis, Anterior/diagnosis , Trabeculectomy/adverse effects
14.
Rom J Ophthalmol ; 68(1): 2-7, 2024.
Article in English | MEDLINE | ID: mdl-38617715

ABSTRACT

Objectives: The first purpose is to present the diagnosis and therapeutic approach in a patient with sterile endophthalmitis associated with triamcinolone acetonide injection. The secondary objective is to assess the incidence of this complication and to summarize the risk factors described in the literature. Case presentation: A 76-year-old male patient presented for painless, unilateral, decreased visual acuity, four days after cataract surgery and simultaneously intravitreal triamcinolone acetonide injection for diabetic macular edema in the right eye. The diagnosis of sterile endophthalmitis was made. Eight days after the presentation, the symptoms subsided, the maximum corrected visual acuity reaching that before the procedures. Discussions: The incidence of sterile endophthalmitis varies in the literature between 0% and 23.8%. Visual prognosis is good, although the pathogenesis is not fully understood. Preservatives in injectable solutions have been suggested, however, there are studies in which inflammation was also present with preservative-free products. The particle size of triamcinolone was analyzed, demonstrating an association between smaller particles and an increased frequency of adverse reactions of this type. History of uveitis, posterior capsule rupture following cataract surgery, and Irvine-Gass syndrome are other associations described. Conclusion: The physiopathological mechanism of sterile endophthalmitis is not fully understood. However, the visual prognosis is good, the final vision being dependent on the underlying pathology.


Subject(s)
Cataract , Diabetic Retinopathy , Endophthalmitis , Macular Edema , Male , Humans , Aged , Triamcinolone Acetonide/adverse effects , Intravitreal Injections , Macular Edema/diagnosis , Macular Edema/drug therapy , Macular Edema/etiology , Endophthalmitis/diagnosis , Endophthalmitis/etiology
15.
Ophthalmologie ; 121(4): 264-271, 2024 Apr.
Article in German | MEDLINE | ID: mdl-38438813

ABSTRACT

Endogenous endophthalmitis represents an ophthalmological emergency requiring immediate diagnostics and treatment. Pathogens should be detected using appropriate methods, such as the Freiburg endophthalmitis set. In bacterial endophthalmitis both Gram-positive and Gram-negative bacteria can be detected. Frequent underlying sources include endocarditis, gastrointestinal or urogenital surgery, indwelling venous catheters, liver abscesses, skin or soft tissue infections, meningitis or less commonly, intravenous drug abuse. The treatment consists of systemic and intraocular administration of antibiotics and vitrectomy. Systemic or intraocular corticosteroids can additionally be considered.


Subject(s)
Endophthalmitis , Eye Infections, Bacterial , Humans , Anti-Bacterial Agents/therapeutic use , Gram-Negative Bacteria , Gram-Positive Bacteria , Eye Infections, Bacterial/diagnosis , Endophthalmitis/diagnosis , Bacteria
16.
Ophthalmologie ; 121(4): 282-290, 2024 Apr.
Article in German | MEDLINE | ID: mdl-38459269

ABSTRACT

BACKGROUND: Endogenous endophthalmitis results from hematogenous spread of bacterial or fungal infection in severely diseased patients. Specific systemic and intraocular therapy is required. The basis for this treatment is causal pathogen detection in blood culture or vitreous sample. However, functional results are limited. OBJECTIVE: The current article provides practical hints for surgical therapy and pathogen detection in patients with endogenous endophthalmitis. METHODS: A retrospective analysis of anonymous data of 68 male and female patients from 2018-2023 from five ophthalmology clinics in Germany was performed. RESULTS: Mean age of affected patients was 71.4 years (31-96 years). Surgical therapy included pars plana vitrectomy (ppV) and intravitreal injection (IVOM). In 44 of 68 patients (65%), 1-3 surgeries were performed, 4-6 surgeries were required in 14/68 (21%) of patients, and 10 or more surgeries were required in 4/68 patients (6%). Pathogen detection was possible in 34% of vitreous specimens and in 11% of anterior chamber samples. Mean initial visual acuity was logMAR 1.5. After treatment and a mean follow-up of 2.5 months, mean visual acuity was logMAR 1.3. Preanalytical methods for specimen collection like the Freiburg endophthalmitis set to optimize pathogen detection are presented. CONCLUSION: Severe inflammatory intraocular reactions in endogenous endophthalmitis necessitate a combination of ppV and repeated IVOM. In addition to providing a vitreous sample, ppV also serves to remove inflammatory fibrin membranes. Early pars plana vitrectomy with specific antibiotic or antifungal therapy should be sought in addition to the focus search and systemic therapy.


Subject(s)
Endophthalmitis , Eye Infections, Fungal , Humans , Male , Female , Aged , Retrospective Studies , Eye Infections, Fungal/diagnosis , Endophthalmitis/diagnosis , Vitrectomy/adverse effects , Hospitals
18.
J Med Case Rep ; 18(1): 171, 2024 Mar 20.
Article in English | MEDLINE | ID: mdl-38504363

ABSTRACT

BACKGROUND: Aeromonas veronii is a very rare and highly pathogenic microorganism. We investigate the clinical characteristics and significance of endogenous endophthalmitis caused by Aeromonas veronii in our patient. CASE PRESENTATION: A 30-year-old Asian women with systemic lupus erythematosus, uremia, and hypertension developed acute infectious endophthalmitis caused by Aeromonas veronii. After emergency vitrectomy and antibiotic therapy, the clinical condition worsened requiring enucleation. CONCLUSIONS: Aeromonas veronii can cause infection in the human eye, which can manifest as acute endophthalmitis. Early diagnosis and targeted therapy are important for successful treatment.


Subject(s)
Aeromonas , Endophthalmitis , Gram-Negative Bacterial Infections , Humans , Female , Adult , Aeromonas veronii , Endophthalmitis/diagnosis , Endophthalmitis/drug therapy , Anti-Bacterial Agents/therapeutic use , Vitrectomy , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/drug therapy
20.
Retina ; 44(7): 1209-1216, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38359396

ABSTRACT

PURPOSE: To explore the clinical value of ß-D-glucan (BDG) testing and metagenomic next-generation sequencing (mNGS) for detecting the pathogens of fungal endophthalmitis (FE). METHODS: This study included 32 cases (32 eyes) with FE and 20 cases (20 eyes) with intraocular inflammation caused by other etiologies. All patients underwent extraction of aqueous humor or vitreous fluid samples for BDG testing and mNGS. The diagnostic performance and total clinical concordance rate of BDG testing and mNGS for FE were evaluated and calculated based on the results of the clinical diagnosis. RESULTS: Among the clinically diagnosed FE, the positivity rates of BDG testing and mNGS (90.63%) were both significantly higher ( P < 0.001) than that of microbial cultures (53.13%). There was 100% consistency in pathogen identification using mNGS and culture identification for culture-positive cases. The area under the curve was 0.927 for BDG testing and 0.853 for mNGS. When the two tests were combined, sensitivity (93.75%), specificity (100.00%), and total clinical concordance rate (96.15%) were all improved, compared with the single tests. CONCLUSION: The positive rates of BDG test and mNGS were markedly higher than those of cultures in FE identification. The combination of these two tests showed improved performance when compared with individual tests.


Subject(s)
Aqueous Humor , Endophthalmitis , Eye Infections, Fungal , High-Throughput Nucleotide Sequencing , Metagenomics , Vitreous Body , beta-Glucans , Humans , Eye Infections, Fungal/diagnosis , Eye Infections, Fungal/microbiology , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Male , Middle Aged , Female , Aqueous Humor/microbiology , beta-Glucans/analysis , Vitreous Body/microbiology , Aged , Metagenomics/methods , Adult , Retrospective Studies , Fungi/isolation & purification , Fungi/genetics , DNA, Fungal/analysis , Proteoglycans , Aged, 80 and over
SELECTION OF CITATIONS
SEARCH DETAIL
...